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Abstract
To improve our understanding of myxomatous degeneration of the valvar tissue as seen in mitral valve prolapse, we have compared the
biosynthetic phenotype of the connective tissue cells in myxomatous segments ðn ¼ 4Þ resected during surgery with that of homologous
segments of normal valves ðn ¼ 4Þ harvested in age-matched organ donors. The steady-state level of mRNA for selected extracellular matrix
macromolecules and metalloproteinases was assessed by quantitative (internal standard controlled) reverse transcriptase-polymerase chain
reaction (RT-PCR). Among the investigated gene products, the decorin mRNA expression was significantly increased in degenerative valve
compared with normal tissue (211 ^ 48 vs. 100 ^ 70, p , 0:02). The level of fibrillin 2 also tended to be increased (194 ^ 88 vs. 100 ^ 81,
p ¼ 0:08). These results suggest that myxomatous valvar tissue is characterized by an overexpression of mRNA for decorin. Owing to the
role of this small leucine-rich proteoglycan in the regulation of fibril assembly and stability, this alteration may account for or is a result of a
defective organization of the collagen and elastic fibers in this disease and contribute to the intrinsic distensibility and fragility of the
myxomatous tissue.
q 2003 Elsevier B.V. All rights reserved.
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1. Introduction
The mitral valve is a complex multilayered tissue created
by specialized, functionally adapted cells. This tissue is
exposed to permanent mechanical constraints, which
requires the accommodation of changes in pressure regi-
men, shape and size throughout the cardiac cycle. Inter-
action between the interstitial cells and their surrounding
extracellular matrix (ECM) leading to phenotypic modifi-
cations of the valvar tissue structure have already been
documented under experimental conditions such as pressure
[1] or volume overload [2]. Idiopathic mitral valve prolapse
(MVP) is a frequent cause of mitral insufficiency (MI) in
industrialized countries and results in a progressive MI in
15% of patients, over a 10–15-year period. Degenerative
valves characterized by excess tissue of both leaflets with
billowing and prolapse (Barlow disease) are clinically
distinguished from other degenerative valves where, most
often, only the median scallop of the posterior leaflet is
involved. It has recently been shown, however, that these
are two fairly distinct entities at the extremes of the
spectrum of degenerative valve disease with only modest
differences in qualitative histology [3].
The myxomatous aspects of the valve and the frequent
association with inherited connective tissue disorders
(Marfan, Ehlers–Danlos, pseudoxanthoma elasticum, etc.)
suggest that an alteration of some components of the
connective tissue may be involved [4]. Screening of families
with MVP has suggested an autosomal dominant inheritance
of that trait with age and sex-dependent expression.
Recently, a first locus for myxomatous MVP (Barlow
disease) was mapped within a few centimorgans interval
[5]. The disabled gene(s) remain(s), however, unidentified.
To gain insight into the mechanism of myxomatous valve
degeneration, we have investigated the biosynthetic pheno-
type of the interstitial cells in the myxomatous tissue by
quantitative reverse transcriptase-polymerase chain reaction
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(RT-PCR) for some representative matrix macromolecules
and metalloproteinases.
2. Material and methods
The study was performed on four prolapsing P2 segments
of the mitral valve (medial scallop of the posterior leaflet)
resected in a quadrangular fashion during mitral valvulo-
plasty (patient’s mean age 51 ^ 12 years). The morpho-
logical aspect was that of fibroelastic deficiency in the four
patients with isolated prolapse of the median scallop of the
posterior leaflet. Homologous segments of four normal
valves were harvested in living multiorgan donors (mean
age 49 ^ 7) free from any valvular disease as judged from
preoperative echo and morphological study. The specimens
were kept frozen in liquid nitrogen until use or fixed for
histological analysis (hematoxylin–eosine and orceine).
This study was approved by the institutional ethics
committee.
2.1. RNA extraction and RT-PCR conditions
Complete strips of the mitral valve (from annulus to free
edge) were used for analysis to prevent the problem of
valvar heterogeneity. The RT-PCR reactions were per-
formed on purified total RNA in an automated thermal
cycler (GeneAmp PCR System 2400 or 9600, Perkin Elmer,
Norwalk, CT) using the GeneAmp Thermostable rtTh
Reverse Transcriptase RNA PCR kit (Perkin Elmer) fol-
lowing previously described conditions and methods [6,7].
2.2. Expression of the results
The optical density (OD) of the amplification product of
the selected mRNA was normalized to the OD of its own
internal standard and expressed in arbitrary units per unit of
28S ribosomal RNA (28S rRNA) measured on a similar
aliquot of the total RNA solution. To obtain comparative
data for each specific mRNA, the whole series of normal
and pathological samples was analyzed simultaneously in
triplicate in the same run. The results in Table 1 are
expressed as mean values ^ standard deviation normalized
to 100 for the control sample. The statistical analyses were
performed using Student’s t-test.
3. Results
3.1. Morphological analysis
Compared to the normal three layers arrangement, the
anatomopathological hallmark of the myxomatous degener-
ation is a disorganization of the valvar tissue and threefold
to fourfold increase in overall thickness of the leaflet
(Fig. 1). Microscopically, myxomatous degeneration con-
sists of infiltration of the valve by a hypertrophic spongiosa
layer that focally invades and disrupts the fibrosa and
auricularis. Continuation of the myxomatous process in the
chordae tendinae was evidenced in the rough zone where the
fibrosa merges into the chordae (Fig. 1). In the myxomatous
valve, the auricularis showed an increased density of elastic
fibers and fibrosis (Fig. 2).
The histological aspect of the four myxomatous valves
was very similar in the texture of the matrix and cell density.
The cell density in the spongiosa was 3.5-fold higher in the
myxomatous, compared to the normal valves (75.2 ^ 8.3
vs. 21.8 ^ 9 cells per high power field). The mean relative
proportion of each layer in the leaflet was also similar if
examined from the free edge to the hinge area. The mor-
phological aspect of the normal valves was very comparable
in the four specimens.
3.2. Cellular phenotype
In this study, we investigated the expression of candidate
genes potentially involved in myxomatous degeneration
Table 1
Steady state level of mRNAs for extracellular matrix macromolecules and
metalloproteinases
Number cycles CTL MMV t-test ( p value)
a1 I 23 100 ^ 29 88 ^ 20 NS
a1 III 23 100 ^ 43 107 ^ 23 NS
Elastin 35 100 ^ 60 99 ^ 28 NS
Fibrillin 1 26 100 ^ 58 118 ^ 30 NS
Fibrillin 2 34 100 ^ 81 194 ^ 88 0.08
Decorin 23 100 ^ 70 211 ^ 48 ,0.02
MMP2 26 100 ^ 25 97 ^ 21 NS
MT1MMP 28 100 ^ 42 115 ^ 33 NS
Fig. 1. Myxomatous degeneration of the posterior leaflet (orceine £ 50).
! Proliferation of the spongiosa; ! infiltration of the chordae by the
myxomatous process.
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based upon morphological observations and/or their associ-
ation with genetic disorders affecting the mitral valve, i.e.
collagen types I and III, elastin, fibrillin 1 and 2, decorin
and the constitutively expressed matrix metalloproteinases,
MMP2 and MT1 MMP. In both Table 1 and Fig. 3, the level
of the investigated mRNAs per unit of 28S rRNA have been
normalized to the mean value of the controls (C) taken as
100 to illustrate the comparative analysis.
The investigated mRNAs are not expressed to the same
extent. In Table 1, the number of cycles required to observe
a measurable signal is provided for information. Collagen I
and III and decorin, requiring less cycles of amplification,
are the most abundant within the investigated mRNAs while
elastin and fibrillin 2 are much less expressed. The indi-
vidual values for each control specimen in Fig. 3 (each open
symbol representing one patient) and for each myxomatous
tissue (closed symbols) illustrate the variability of the
mRNA expression. The range of variation of the individual
values is remarkably narrow when considering the genetic
heterogeneity of the human race except for decorin and
fibrillin 2, which displays a somewhat higher variation than
that of the other mRNAs. The mean values detailed in
Table 1 demonstrate an overall similarity between C and
MMV for most gene products except for the decorin mRNA
level that is significantly higher in the pathological valves
while that of fibrillin 2 tends also to be increased.
4. Discussion
The steady state level of mRNA expression per unit of
28S rRNA for collagen I and III is very similar in the normal
and myxomatous tissues. An estimate of the relative number
of copies of their mRNA has been calculated and gives a
distribution of 46% type I—54% type III in the control valve
and 40% type I—60% type III in the myxomatous samples.
This difference, although not statistically significant
ðp ¼ 0:11Þ, might account for an increased proportion of
collagen III in MMV. Indeed, mechanical stress has been
reported to upregulate collagen synthesis in the mitral valve
of experimental MI resulting from papillar muscle dysfunc-
tion [2]. Such a regulation is a common reaction of the
connective tissue cells to increased tension [7]. The collagen
network depends on a balance between synthesis and degra-
dation and its ultimate and functional structure results from
the assembly of collagen fibrils that can be modulated by
various factors, among which minor collagens, degrading
enzymes and proteoglycans [8]. Myxomatous tissue is
characterized by an altered architectural organization of the
collagen bundles, which are sparse, irregularly arranged
and focally organized in spiraling substructures [4]. These
abnormal polymers that retain their axial periodicity occupy
a volume considerably larger than normal. Such abnormal
organization and structure of the fibrils can be observed in
diseases such as Marfan or Ehlers–Danlos type IV [11] in
which an abnormal fibrillin 1 or defective collagen III,
respectively, are likely to explain the weakness of the
valve. It has been suggested that dysfunctions in enzymes
responsible for the complex post-translational processing of
procollagen could account for weakened extracellular
matrix in the valve leading to prolapse. All the enzymatic
deficiencies of this type are recessive trait making this
hypothesis unlikely in the usual myxomatous degeneration
that is autosomal dominant.
Semiquantitative immunohistochemical studies [9] have
shown that myxomatous valves express increased levels of
the interstitial collagenases MMP1 and MMP13 and the
gelatinases MMP2 and MMP9. According to these studies,
activation of MMPs is likely to play a role in the remodeling
of the extracellular matrix, as seen in other diseases such as
aneurysms, aortic valves in Marfan, etc. [10]. The levels of
mRNA coding for the matrix metalloproteinases, MMP2
and its membrane-bound activator MT1MMP were similar
in the control and myxomatous valves. No MMP3 mRNA
was detected (data not shown), an enzyme also known to be
induced by mechanical relaxation. A comparative screening
of the expression of other proteinases is planned in the near
future.
The increased level of decorin mRNA observed in our
study suggests that this proteoglycan participates in the
process. The small leucine-rich proteoglycans (lumican,
biglycan and decorin) are involved in fibrillogenesis of
collagen and elastin [12]. Decorin affects collagen types I
and II fibrillogenesis in a core protein-dependent fashion
by reducing the diameter of the collagen fibrils. Transgenic
mice lacking decorin exhibit fragile skin and irregular
collagen structures [13]. It has recently been shown that
lumican and decorin have a different and distinct effect
on fibril formation and independent binding sides on the
collagen fibril. They seem to stabilize the fibrils at the
same time as they limit their growth, preventing fibril
Fig. 2. Myxomatous valve (orceine £ 200). A, auricularis; S, spongiosa; F,
fibrosa. p p Increased density of elastic fibers in the auricularis layer.
p Fibrosis in the auricularis layer.
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anastomosis and reducing their heterogeneity in diameter.
Similarly, although not significant at the 5% level, the
increased expression of fibrillin 2 is worth considering.
This protein also associated in the elastic fibers has been
claimed to regulate fibrillogenesis of the force bearing
copolymers of elastin and fibrillin 1 [14]. We raise
the possibility that an increased decorin production might
represent a compensation mechanism related to the
increased extracellular space created by defective fibrous
polymers. We have observed such a process in the
dermatosparactic skin containing disorganized fibers
made of collagen precursors [15].
Fig. 3. Individual values of the mRNA levels measured in normal (open symbols) and myxomatous (closed symbols) valves. The results are normalized to the
control values taken as 100. Each patient is represented by one individual symbol.
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From our results and the literature, it can be proposed
that myxomatous degeneration represents a final common
pathway of valvar remodeling of potentially diverse etio-
logy. It could be a result of exposition to abnormal stress as
it might also depend on a defective ability of the cells to
transduce the mechanical signals resulting from their
interaction with the extracellular support. In the majority
of cases, however, the primary deficiency is unknown, but
the context points to genetic abnormalities, which result in
an incapacity of the valve to bear or cope with normal stress.
This may result from an abnormal morphology of the valve
or mild defect at the cellular or molecular level. In this
hypothesis, myxomatous degeneration should occur mainly
in the median part of the posterior scallop, which is believed
to be submitted to higher mechanical constraint. The
activation of interstitial connective tissue cells in response
to abnormal mechanical stress may appear as an adaptative
response to enhance the capacity of the valvar tissue to
sustain the mechanical constraint. Similar to what has been
shown in cartilaginous tissue, where the proteoglycans are
upregulated by increased pressure, the valvar spongiosa,
which is believed to have a protective mechanical function
by cushioning compressive stress and minimizing shear
between fibrosa and auricularis is enhanced. If transiently
adaptative, this response may lead to progressive alteration
of the valvar tissue, possibly via the effect of an accu-
mulation of proteoglycans among which decorin. Its
increased concentration and its potential effect on fibrillo-
genesis of collagen and elastic fibers may perpetuate a
vicious circle of reduced mechanical resistance by increas-
ing the stress exerted on the valve, especially when mitral
valve regurgitation occurs. In this scenario, repair surgery,
although dealing with abnormal tissue may halt this process
by reducing the undue stress on the leaflets and subvalvar
structures. At the present time, it is not possible to determine
if the overexpression of decorin is the cause or consequence
of defective architectural organization of the fibrillar com-
ponents of the extracellular matrix in myxomatous MVP.
This is the subject of our current investigation.
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Appendix A. Conference discussion
Dr K. Zehr (Rochester, MN, USA): As you alluded earlier in your
presentation, Barlow’s disease has often been thought of as a form fruste of
Marfan syndrome which has been pinned down to the fibrillin 1 gene.
Fleischer et al. from Hopkins years ago looked at Marfan tissue and found
significant elastic disruption. I find it very interesting that fibrillin 1 was the
same between your controls and your myxomatous patients.
Do you have access to Marfan P2 sections? We often fix the mitral valve
regurgitation in the Marfan leaflets by doing P2 resections. Do you have
access to that tissue and have you looked at these tissues to see if the
changes that you found are present in Marfan tissue as well?
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Dr Radermecker: No, we haven’t, but we agree with you, and I think
that most surgeons interested in the mitral valve concur by saying that
myxomatous degeneration is just the final common pathway of a
dysfunctioning leaflet, no matter the cause.
You pointed out Marfan with the problem of fibrillin 1, but Ehlers–
Danlos type 4 also shows myxomatous floppy valves which are nearly the
same as a Marfan valves, although the disorder is known in this case: it is
the defect in the collagen type 3. This is just to point out that several known
gene defects, fibrillin, type 3 collagen, may just lead to the same gross
morphological disease, which is myxomatous degeneration.
That is why we are interested, even in form fruste of myxomatous mitral
valve prolapse located only to P2, in understanding why someone let’s say
45 years old with apparently normal connective tissue everywhere else, has a
dysfunctioning P2 and a failure of the connective tissue to support his valve
in this particular area. We believe that discrete gene defects or defective
signaling between the cells and the extracellular matrix may be involved,
and it is in that direction that we are currently pursuing our research.
Dr A. El-Ghafary (Cairo, Egypt): I think Dr Barlow from South Africa
has found that 25% of the population has got mitral valve prolapse but are
still asymptomatic, number one.
Number two, he did mention that one of the main causes of mitral valve
prolapse probably in his group in South Africa is due to rheumatic origin.
That is number two. So there is a big discrepancy between collagen which
could not be seen as abnormal fibrillin and those patients who have got
mitral valve prolapse and have got underlying heart disease like rheumatic
heart disease in origin.
Did you correlate between the symptoms of the patients prior to surgery
and the clinical data, because some of them have got severe arrhythmia of
their prolapse, the second have got chest pain, and the third group have got
also loss of consciousness? So did you correlate the abnormality that you
have discovered in relation to the clinical data of those patients prior to the
surgery or not?
Dr Radermecker: We don’t have a follow-up of these patients, at least
they haven’t been followed so long before the operation so that we cannot
tell you anything about the evolution of their disease. Concerning your
previous remark, there is no possibility that degenerative mitral valve
disease has been confounded with rheumatic etiology in this study. We
agree with you that mitral valve prolapse is very frequent in the population,
as published by Procacci et al. However, there is constant confusion
between what I would call myxomatous mitral valve prolapse limited to P2
and the billowing and prolapsing valve which is the characteristic of
Barlow’s disease. These are two visible aspects of a disease at the extremes
of a continuum. The disease is actually degenerative mitral valve disease
because we have no better way to call it at this point in time.
Mr B. Keogh (Birmingham, UK): May I simply make an observation
with respect to your diagram. I think in medicine it is becoming
increasingly clear that very, very few diseases, particularly those with a
variable phenotype, are due to a single gene defect, and that is no better
illustrated, for example, than by hypotrophic obstructive cardiomyopathy.
Therefore, I find myself wondering whether your ‘gene defect’ should
be in the plural and the question remains as to whether, in fact, the gene
defect actually causes the morphological anomaly. Invariably when you see
one morphological anomaly in the valve it looks as though similar problems
are about to occur somewhere else and the issue of physical influences
arises.
So you might start looking at valves where the morphological anomaly
is due to something clearly physical, such as old, treated infective
endocarditis, and if you start to see the subsequent interstitial cell changes
there, then you know that morphological anomalies per se can create a
problem. Otherwise I would suggest that the morphological anomaly should
sit in between multiple gene defects and the rest of your boxes. It is just a
thought.
Dr Radermecker: I agree, for the plural of ‘gene defects’. And to add a
little something, let me just add that maybe there is no gene defect but just a
problem of regulation of functioning genes. So the situation is quite
complex and this accounts for what we find in the clinical situation. There is
a spectrum of degenerative valves.
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